Fourteen feline nodal lymphomas previously diagnosed as Hodgkin-like lymphoma (HLL) were studied through histologic, immunohistochemical, and molecular analyses to further characterize feline HLL. The cohort comprised 12 domestic shorthair and 2 Maine coon cats, with a male/female ratio of 1.3 and a median age of 9.5 years. Reed–Sternberg and Hodgkin cells were observed in 14/14 HLLs, while a minority of cells resembling lymphocyte-predominant cells were observed in 5/14 (36%) cases. Neoplastic cells were embedded in a mixed reactive background mainly composed of T and B lymphocytes and histiocytes. Necrosis was present in 9/14 (64%) cases. Various percentages of neoplastic cells were positive for CD30, PAX5, and MUM1 in 14/14 cases and for CD20 in 12/14 (86%) cases. Polymerase chain reaction (PCR) for antigen receptor rearrangements (PARR) by agarose gel electrophoresis identified clonal immunoglobulin heavy chain (IGH) in 9/14 (64%) cases, clonal T-cell receptor-gamma (TRG) rearrangements in 4/14 (29%) cases, and polyclonal IGH and TRG in 1 case. The predominance of Reed–Sternberg and Hodgkin cells and a CD30+/PAX5+/MUM1+ immunophenotype were consistent findings in this case series and align with the human classic form of Hodgkin lymphoma (HL). However, in contrast to the human tumor, most feline HLLs express CD20. Based on the human HL classification, feline HLLs were further categorized as lymphocyte-rich (6/14, 43%), mixed cellularity (4/14, 29%), nodular sclerosis (2/14, 14%), and lymphocyte-depleted (2/14, 14%). Feline HLL is a complex neoplasm that requires refinement of diagnostic criteria to improve classification and management.
AlaggioRAmadorCAnagnostopoulosI, et al. The 5th edition of the World Health Organization classification of haematolymphoid tumours: lymphoid neoplasms. Leukemia. 2022;36(7):1720–1748.
2.
Al SaatiTGaloinSGravelS, et al. IgH and TcR-γ gene rearrangements identified in Hodgkin’s disease by PCR demonstrate lack of correlation between genotype, phenotype, and Epstein- Barr virus status. J Pathol. 1997;181(4):387–393.
3.
AnsellSM.Hodgkin lymphoma: diagnosis and treatment. Mayo Clin Proc. 2015;90(11):1574–1583.
4.
CarboneAGloghiniAAldinucciD, et al. Expression pattern of MUM1/IRF4 in the spectrum of pathology of Hodgkin’s disease. Br J Haematol. 2002;117(2):366–372.
5.
CarminatoATecillaMRoccabiancaP, et al. CD30 cross-reactivity and expression in feline normal tissues and lymphomas. Vet Pathol. 2020;57(1):49–55.
6.
ConnorsJMCozenWSteidlC, et al. Hodgkin lymphoma. Nat Rev Dis Primer. 2020;6(1):61.
7.
DayMJKyaw-TannerMSilkstoneMA, et al. T-cell-rich B-cell lymphoma in the cat. J Comp Pathol. 1999;120(2):155–167.
8.
DürkopHLatzaUHummelM, et al. Molecular cloning and expression of a new member of the nerve growth factor receptor family that is characteristic for Hodgkin’s disease. Cell. 1992;68(3):421–427.
9.
EberleFCManiHJaffeES.Histopathology of Hodgkin’s lymphoma. Cancer J. 2009;15(2):129–137.
FendFQuintanilla-MartinezL. Hodgkin lymphoma. In HsiED, ed. Foundations in Diagnostic Pathology, Hematopathology. Amsterdam, Netherlands: Elsevier; 2018:363–393.
12.
FossHDReuschRDemelG, et al. Frequent expression of the B-cell-specific activator protein in Reed-Sternberg cells of classical Hodgkin’s disease provides further evidence for its B-cell origin. Blood. 1999;94(9):3108–3113.
13.
GruffermanSColePSmithPG, et al. Hodgkin’s disease in siblings. N Engl J Med. 1977;296(5):248–250.
14.
HoltEGoldschmidtMHSkorupskiK.Extranodal conjunctival Hodgkin’s-like lymphoma in a cat. Vet Ophthalmol. 2006;9(3):141–144.
15.
JonaASzodorayPIllésA.Immunologic pathomechanism of Hodgkin’s lymphoma. Exp Hematol. 2013;41(12):995–1004.
16.
KanzlerHKüppersRHansmannML, et al. Hodgkin and Reed-Sternberg cells in Hodgkin’s disease represent the outgrowth of a dominant tumor clone derived from (crippled) germinal center B cells. J Exp Med. 1996;184(4):1495–1505.
17.
KellerSMVernauWMoorePF.Clonality testing in veterinary medicine: a review with diagnostic guidelines. Vet Pathol. 2016;53(4):711–725.
18.
KhanMRAhmadAKayaniN, et al. Expression of PAX-5 in B cell Hodgkin and non Hodgkin lymphoma. Asian Pac J Cancer Prev. 2018;19(12):3463–3466.
19.
KokovicINovakovicBJCerkovnikP, et al. Clonality analysis of lymphoid proliferations using the biomed-2 clonality assays: a single institution experience. Radiol Oncol. 2014;48(2):155–162.
20.
LaurentCDoCGourraudPA, et al. Prevalence of common non-Hodgkin lymphomas and subtypes of Hodgkin lymphoma by nodal site of involvement: a systematic retrospective review of 938 cases. Med U S. 2015;94(25):e987.
21.
LynchHTMarcusJNLynchJF.Genetics of Hodgkin’s and non-Hodgkin’s lymphoma: a review: genetics. Cancer Invest. 1992;10(3):247–256.
22.
MarconatoLMagaIIussichS, et al. Histologic, phenotypic, and molecular characterization of feline Hodgkin-like lymphoma with classical Reed-Sternberg cells. Vet Comp Oncol. 2024;22(4):457–650.
23.
Mhawech-FaucegliaPSaxenaRZhangS, et al. Pax-5 immunoexpression in various types of benign and malignant tumours: a high-throughput tissue microarray analysis. J Clin Pathol. 2007;60(6):709–714.
24.
MoorePFWooJCVernauW, et al. Characterization of feline T cell receptor gamma (TCRG) variable region genes for the molecular diagnosis of feline intestinal T cell lymphoma. Vet Immunol Immunopathol. 2005;106(3–4):167–178.
25.
MurphyBGEckstrandCCastilloD, et al. Multiple, independent T cell lymphomas arising in an experimentally FIV-infected cat during the terminal stage of infection. Viruses. 2018;10(6):1–16.
26.
NewtonJAde VicenteFHauglandSP, et al. Extra-nodal subcutaneous Hodgkin’s-like lymphoma and subsequent regression in a cat. J Feline Med Surg. 2015;17(6):709–714.
27.
PetitjeanBJardinFJolyB, et al. Pyothorax-associated lymphoma: a peculiar clinicopathologic entity derived from B cells at late stage of differentiation and with occasional aberrant dual B- and T-cell phenotype. Am J Surg Pathol. 2002;26(6):724–732.
28.
PiccalugaPPAgostinelliCGazzolaA, et al. Pathobiology of Hodgkin lymphoma. Adv Hematol. 2011;2011:1–18.
29.
PierceJMRMehtaA.Diagnostic, prognostic and therapeutic role of CD30 in lymphoma. Expert Rev Hematol. 2017;10(1):29–37.
30.
PileriSAAscaniSLeonciniL, et al. Hodgkin’s lymphoma: the pathologist’s viewpoint. J Clin Pathol. 2002;55(3):162–176.
31.
PinkusGSSaidJW.Hodgkin’s disease, lymphocyte predominance type, nodular—a distinct entity? Unique staining profile for L & H variants of Reed-Sternberg cells defined by monoclonal antibodies to leukocyte common antigen, granulocyte-specific antigen, and B-cell-specifi. Am J Pathol. 1985;118(1):1–6.
32.
RadtanakatikanonAMoorePFKellerSM, et al. Novel clonality assays for T cell lymphoma in cats targeting the T cell receptor beta, T cell receptor delta, and T cell receptor gamma loci. J Vet Intern Med. 2021;35(6):2865–2875.
33.
RopertoFDamianoSGalatiP.Hodgkin’s disease in a cat. Zentralblatt Für Veterinärmedizin Reihe A. 1983;30(3):182–188.
34.
RoutEDBurnettRCYoshimotoJA, et al. Assessment of immunoglobulin heavy chain, immunoglobulin light chain, and T-cell receptor clonality testing in the diagnosis of feline lymphoid neoplasia. Vet Clin Pathol. 2019;48(S1):45–58.
35.
SaarinenSPukkalaEVahteristoP, et al. High familial risk in nodular lymphocyte-predominant Hodgkin lymphoma. J Clin Oncol. 2013;31(7):938–943.
36.
SakataniAIgawaTOkataniT, et al. Clinicopathological significance of CD79a expression in classic Hodgkin lymphoma. J Clin Exp Hematop. 2020;60(3):78–86.
37.
SeitzVHummelMMarafiotiT, et al. Detection of clonal T-cell receptor gamma-chain gene rearrangements Reed-Sternberg cells of classic Hodgkin disease. Blood. 2000;95(10):3020–3024.
38.
ShanbhagSAmbinderRF.Hodgkin lymphoma: a review and update on recent progress. CA Cancer J Clin. 2018;68(2):116–132.
39.
SteeleKESaundersGKColemanGD.T-cell-rich B-cell lymphoma in a cat. Vet Pathol. 1997;34(1):47–49.
40.
SteinbergJDKeatingJH.What is your diagnosis? Cervical mass in a cat. Vet Clin Pathol. 2008;37(3):323–327.
41.
SteinHSwerdlowSHGascoyneRD, et al. Hodgkin lymphomas. In: SwerdlowSHCampoEHarrisNL, et al., eds. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Lyon: International Agency for Research on Cancer; 2017:423–442.
42.
TerenziABolognesiAPasqualucciL, et al. Anti-CD30 (BER-H2) immunotoxins containing the type-1 ribosome-inactivating proteins momordin and PAP-S (pokeweed antiviral protein from seeds) display powerful antitumour activity against CD30+ tumour cells in vitro and in SCID mice. Br J Haematol. 1996;92(4):872–879.
43.
TownsendWLinchD.Hodgkin’s lymphoma in adults. Lancet. 2012;380(9844):836–847.
ValliVEBienzleDMeutenDJ. Tumors of the hemolymphatic system. In: Tumors in Domestic Animals. Hoboken, NJ: John Wiley; 2017:203–329.
46.
VezzaliEParodiALMarcatoPS, et al. Histopathologic classification of 171 cases of canine and feline non-Hodgkin lymphoma according to the WHO. Vet Comp Oncol. 2010;8(1):38–49.
47.
WaltonRMHendrickMJ.Feline Hodgkin’s-like lymphoma: 20 cases (1992-1999). Vet Pathol. 2001;38(5):504–511.
48.
WangHWBalakrishnaJPPittalugaS, et al. Diagnosis of Hodgkin lymphoma in the modern era. Br J Haematol. 2019;184(1):45–59.
49.
WatanabeKYamashitaYNakayamaA, et al. Varied B-cell immunophenotypes of Hodgkin/Reed-Sternberg cells in classic Hodgkin’s disease. Histopathology. 2000;36(4):353–361.
50.
WeinrebMDayPJRNiggliF, et al. The role of Epstein-Barr virus in Hodgkin’s disease from different geographical areas. Arch Dis Child. 1996;74(1):27–31.
51.
WeissATHAKlopfleischRGruberAD. T-cell receptor γ chain variable and joining region genes of subgroup 1 are clonally rearranged in feline B- and T-cell lymphoma. J Comp Pathol. 2011;144(2–3):123–134.
52.
WernerJAWooJCVernauW, et al. Characterization of feline immunoglobulin heavy chain variable region genes for the molecular diagnosis of B-cell neoplasia. Vet Pathol. 2005;42(5):596–607.
53.
YoshinoYChambersJKNakamoriT, et al. Primary cerebellar lymphoma with Hodgkin lymphoma–like morphology in a cat. J Vet Diagn Invest. 2017;29(5):707–710.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
